(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 5.22% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Smith & Nephew's revenue in 2025 is $5,810,000,000.On average, 2 Wall Street analysts forecast SNN's revenue for 2025 to be $5,370,430,545,483, with the lowest SNN revenue forecast at $5,355,268,205,670, and the highest SNN revenue forecast at $5,385,592,885,296. On average, 2 Wall Street analysts forecast SNN's revenue for 2026 to be $5,654,587,275,700, with the lowest SNN revenue forecast at $5,622,529,130,307, and the highest SNN revenue forecast at $5,686,645,421,094.
In 2027, SNN is forecast to generate $5,941,179,635,034 in revenue, with the lowest revenue forecast at $5,905,193,763,408 and the highest revenue forecast at $5,977,165,506,660.